Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry). (2023)
https://pubmed.ncbi.nlm.nih.gov/36454054/

Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry. (2023)
https://pubmed.ncbi.nlm.nih.gov/36201124/

Validation of the Toronto Psoriatic Arthritis Screening 2 (TOPAS-2) questionnaire in an Argentinian population. (2023)
https://doi.org/10.1016/j.rcreu.2022.12.003

Spanish Validation of the GEPARD Questionnaire for the Detection of Psoriatic Arthritis in Argentinian Patients with Psoriasis (2019)
https://pubmed.ncbi.nlm.nih.gov/30654384/

Magnetic Resonance Imaging in Psoriatic Arthritis: A Descriptive Study of Indications, Features and Effect on Treatment Change (2017)
https://pubmed.ncbi.nlm.nih.gov/28700527/

Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort (2016)
https://pubmed.ncbi.nlm.nih.gov/28002334/

Secukinumab: a promising therapeutic option in spondyloarthritis (2016)
https://pubmed.ncbi.nlm.nih.gov/27437696/

Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology (2015)
https://pubmed.ncbi.nlm.nih.gov/26573206/

Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria (2014)
https://pubmed.ncbi.nlm.nih.gov/24150746/